BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Multiple Myeloma
NCI Information
Clinical Trials
Multiple Myeloma Trials
Bone Marrow Transplant (BMT) Trials
Support Groups
Effects of Treatment
Podcast
Bone Marrow and Stem Cell Transplantation
Other Resouces
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201107230
Principal Investigator:
Stockerl-Goldstein, Keith
Title:
A Phase 3, Randomized Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma
Phase:
III
Disease Site:
Multiple Myeloma
Participating Site(s):
Main Campus
Map and Directions
West County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The purpose of this research study is to determine if an experimental drug, elotuzumab, given with lenalidomide and dexamethasone is more effective at treating relapsed or resistant to treatment multiple myeloma compared with the standard treatment of lenalidomide and dexamethasone alone. This study will also assess the safety of elotuzumab given with lenalidomide and dexamethasone compared with lenalidomide and dexamethasone alone.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)